Concepts (170)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proteins | 14 | 2014 | 45 | 3.620 |
Why?
|
Crystallization | 34 | 2025 | 83 | 3.480 |
Why?
|
Amyloid beta-Peptides | 4 | 2023 | 18 | 3.090 |
Why?
|
Muramidase | 12 | 2017 | 33 | 3.050 |
Why?
|
Amyloid | 6 | 2023 | 9 | 2.870 |
Why?
|
Hemoglobin, Sickle | 11 | 2019 | 12 | 2.860 |
Why?
|
Hemin | 8 | 2023 | 18 | 2.650 |
Why?
|
Antimalarials | 7 | 2024 | 17 | 2.630 |
Why?
|
Kinetics | 21 | 2023 | 78 | 2.180 |
Why?
|
Heme | 5 | 2017 | 7 | 1.950 |
Why?
|
Solutions | 19 | 2022 | 31 | 1.810 |
Why?
|
Hemeproteins | 6 | 2024 | 15 | 1.770 |
Why?
|
Quinolines | 3 | 2023 | 21 | 1.580 |
Why?
|
Microscopy, Atomic Force | 15 | 2025 | 37 | 1.200 |
Why?
|
Peptide Fragments | 3 | 2023 | 12 | 1.190 |
Why?
|
Protein Conformation | 13 | 2017 | 45 | 1.120 |
Why?
|
Scattering, Radiation | 11 | 2014 | 18 | 1.100 |
Why?
|
Models, Chemical | 8 | 2017 | 35 | 1.000 |
Why?
|
Protein Multimerization | 4 | 2016 | 16 | 0.990 |
Why?
|
Light | 9 | 2014 | 43 | 0.960 |
Why?
|
Malaria | 2 | 2023 | 6 | 0.930 |
Why?
|
Chloroquine | 4 | 2024 | 10 | 0.920 |
Why?
|
Anemia, Sickle Cell | 5 | 2019 | 10 | 0.910 |
Why?
|
Insulin | 4 | 2006 | 29 | 0.910 |
Why?
|
Thermodynamics | 13 | 2017 | 42 | 0.890 |
Why?
|
Water | 7 | 2025 | 37 | 0.890 |
Why?
|
Models, Molecular | 8 | 2017 | 84 | 0.860 |
Why?
|
Animals | 15 | 2023 | 1798 | 0.850 |
Why?
|
Humans | 26 | 2024 | 5357 | 0.830 |
Why?
|
Minerals | 1 | 2022 | 2 | 0.820 |
Why?
|
Biophysics | 4 | 2006 | 16 | 0.810 |
Why?
|
Alzheimer Disease | 1 | 2022 | 85 | 0.750 |
Why?
|
Mutation, Missense | 1 | 2021 | 7 | 0.740 |
Why?
|
Erythrocytes | 4 | 2024 | 12 | 0.740 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2021 | 30 | 0.730 |
Why?
|
Hemoglobin C | 4 | 2003 | 4 | 0.690 |
Why?
|
Temperature | 10 | 2013 | 59 | 0.680 |
Why?
|
Solvents | 8 | 2025 | 23 | 0.670 |
Why?
|
Static Electricity | 3 | 2015 | 13 | 0.610 |
Why?
|
Hemoglobins | 3 | 2009 | 8 | 0.600 |
Why?
|
Plasmodium falciparum | 3 | 2024 | 9 | 0.570 |
Why?
|
Phase Transition | 4 | 2012 | 7 | 0.560 |
Why?
|
Liquid Crystals | 1 | 2015 | 2 | 0.510 |
Why?
|
Molecular Dynamics Simulation | 3 | 2021 | 30 | 0.500 |
Why?
|
Nanoparticles | 2 | 2020 | 74 | 0.490 |
Why?
|
Microscopy | 2 | 2015 | 36 | 0.490 |
Why?
|
Hydrogen-Ion Concentration | 5 | 2015 | 37 | 0.480 |
Why?
|
Erythrocyte Membrane | 2 | 2015 | 3 | 0.480 |
Why?
|
Models, Biological | 2 | 2019 | 124 | 0.470 |
Why?
|
Octanols | 1 | 2013 | 3 | 0.450 |
Why?
|
Artemisinins | 2 | 2024 | 7 | 0.420 |
Why?
|
Crystallography, X-Ray | 4 | 2017 | 38 | 0.420 |
Why?
|
Biopolymers | 3 | 2008 | 4 | 0.380 |
Why?
|
Surface Properties | 3 | 2017 | 75 | 0.380 |
Why?
|
Monte Carlo Method | 4 | 2020 | 16 | 0.370 |
Why?
|
Chemistry, Physical | 2 | 2007 | 3 | 0.350 |
Why?
|
Solubility | 3 | 2019 | 11 | 0.330 |
Why?
|
Polymers | 2 | 2006 | 39 | 0.330 |
Why?
|
Chemistry Techniques, Analytical | 1 | 2009 | 1 | 0.330 |
Why?
|
Viscoelastic Substances | 1 | 2009 | 2 | 0.330 |
Why?
|
Oxygen | 3 | 2019 | 20 | 0.320 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 3 | 2015 | 15 | 0.320 |
Why?
|
Multienzyme Complexes | 2 | 2007 | 4 | 0.320 |
Why?
|
Protein Folding | 3 | 2021 | 15 | 0.320 |
Why?
|
Diffusion | 4 | 2017 | 18 | 0.290 |
Why?
|
Protein Structure, Quaternary | 4 | 2016 | 6 | 0.290 |
Why?
|
Particle Size | 3 | 2013 | 43 | 0.280 |
Why?
|
Apoferritins | 5 | 2005 | 5 | 0.270 |
Why?
|
Algorithms | 4 | 2014 | 261 | 0.270 |
Why?
|
Ferritins | 2 | 2003 | 2 | 0.260 |
Why?
|
Chickens | 2 | 2015 | 22 | 0.250 |
Why?
|
Cholesterol | 1 | 2025 | 18 | 0.240 |
Why?
|
Naphthyridines | 1 | 2024 | 2 | 0.240 |
Why?
|
Drug Resistance | 1 | 2024 | 3 | 0.240 |
Why?
|
Bacteriorhodopsins | 1 | 2004 | 1 | 0.240 |
Why?
|
Dimerization | 2 | 2020 | 14 | 0.240 |
Why?
|
Swine | 3 | 2013 | 48 | 0.230 |
Why?
|
Time Factors | 4 | 2006 | 176 | 0.230 |
Why?
|
Papillomavirus Infections | 1 | 2023 | 7 | 0.210 |
Why?
|
Mouth Neoplasms | 1 | 2023 | 8 | 0.210 |
Why?
|
Plaque, Amyloid | 1 | 2022 | 8 | 0.210 |
Why?
|
Viscosity | 3 | 2015 | 11 | 0.210 |
Why?
|
Interferometry | 1 | 2002 | 6 | 0.210 |
Why?
|
Rats | 1 | 2022 | 250 | 0.190 |
Why?
|
MCF-7 Cells | 1 | 2021 | 17 | 0.190 |
Why?
|
Amino Acid Substitution | 1 | 2021 | 17 | 0.190 |
Why?
|
Microscopy, Confocal | 2 | 2014 | 49 | 0.180 |
Why?
|
Adsorption | 2 | 2018 | 46 | 0.180 |
Why?
|
Computer Simulation | 3 | 2006 | 180 | 0.180 |
Why?
|
Entropy | 3 | 2008 | 11 | 0.180 |
Why?
|
Avidin | 1 | 2020 | 15 | 0.180 |
Why?
|
Osmolar Concentration | 2 | 2015 | 17 | 0.180 |
Why?
|
Molecular Structure | 1 | 2020 | 85 | 0.180 |
Why?
|
Serum Albumin, Bovine | 2 | 2011 | 20 | 0.170 |
Why?
|
Protein Binding | 2 | 2015 | 118 | 0.170 |
Why?
|
Elasticity | 2 | 2011 | 31 | 0.170 |
Why?
|
Erythrocytes, Abnormal | 1 | 2019 | 1 | 0.170 |
Why?
|
Crystallography | 2 | 2014 | 2 | 0.170 |
Why?
|
Mutation | 3 | 2024 | 135 | 0.160 |
Why?
|
Dynamic Light Scattering | 2 | 2015 | 3 | 0.160 |
Why?
|
Multiprotein Complexes | 2 | 2010 | 6 | 0.150 |
Why?
|
Spectrophotometry | 3 | 2017 | 13 | 0.150 |
Why?
|
Proteostasis Deficiencies | 1 | 2017 | 2 | 0.150 |
Why?
|
Microscopy, Electron, Scanning | 2 | 2017 | 33 | 0.150 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2017 | 10 | 0.140 |
Why?
|
Binding Sites | 1 | 2017 | 69 | 0.140 |
Why?
|
Biomechanical Phenomena | 3 | 2019 | 173 | 0.140 |
Why?
|
Molecular Conformation | 2 | 2006 | 26 | 0.140 |
Why?
|
Hemoglobin A | 1 | 2015 | 2 | 0.130 |
Why?
|
Urea | 1 | 2015 | 5 | 0.130 |
Why?
|
Hemolysis | 1 | 2015 | 1 | 0.130 |
Why?
|
Renal Dialysis | 1 | 2015 | 2 | 0.130 |
Why?
|
Photolysis | 2 | 2006 | 3 | 0.130 |
Why?
|
Healthy Volunteers | 1 | 2015 | 42 | 0.130 |
Why?
|
Deuterium Exchange Measurement | 1 | 2015 | 1 | 0.130 |
Why?
|
Protein Unfolding | 1 | 2015 | 2 | 0.130 |
Why?
|
Vacuoles | 1 | 2015 | 2 | 0.120 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2006 | 53 | 0.120 |
Why?
|
Ethanol | 1 | 2015 | 45 | 0.120 |
Why?
|
Biophysical Phenomena | 2 | 2003 | 10 | 0.110 |
Why?
|
Cluster Analysis | 1 | 2012 | 24 | 0.100 |
Why?
|
Protein Structure, Tertiary | 1 | 2012 | 30 | 0.100 |
Why?
|
Mice | 2 | 2023 | 716 | 0.100 |
Why?
|
Cattle | 1 | 2011 | 20 | 0.090 |
Why?
|
Cholic Acids | 1 | 2010 | 1 | 0.090 |
Why?
|
Dimyristoylphosphatidylcholine | 1 | 2010 | 3 | 0.090 |
Why?
|
Protein Stability | 1 | 2009 | 4 | 0.080 |
Why?
|
Electrochemistry | 1 | 2009 | 9 | 0.080 |
Why?
|
Microelectrodes | 1 | 2009 | 13 | 0.080 |
Why?
|
Cytosol | 1 | 2009 | 6 | 0.080 |
Why?
|
Macromolecular Substances | 1 | 2007 | 7 | 0.070 |
Why?
|
Chemical Phenomena | 1 | 2007 | 1 | 0.070 |
Why?
|
Bacillus subtilis | 1 | 2007 | 18 | 0.070 |
Why?
|
Methods | 1 | 2006 | 3 | 0.070 |
Why?
|
Sulfates | 1 | 2006 | 6 | 0.070 |
Why?
|
Methionine | 1 | 2006 | 3 | 0.070 |
Why?
|
Automation | 1 | 2006 | 12 | 0.070 |
Why?
|
Ions | 1 | 2006 | 9 | 0.070 |
Why?
|
Hydrogen Bonding | 1 | 2006 | 19 | 0.070 |
Why?
|
Models, Statistical | 1 | 2006 | 68 | 0.070 |
Why?
|
Nonlinear Dynamics | 1 | 2006 | 13 | 0.070 |
Why?
|
Enzyme Stability | 1 | 2005 | 3 | 0.060 |
Why?
|
2-Propanol | 1 | 2025 | 2 | 0.060 |
Why?
|
Microfluidics | 1 | 2025 | 8 | 0.060 |
Why?
|
Glycerides | 1 | 2004 | 1 | 0.060 |
Why?
|
Halobacterium salinarum | 1 | 2004 | 1 | 0.060 |
Why?
|
Acetone | 1 | 2003 | 1 | 0.060 |
Why?
|
Calibration | 1 | 2003 | 9 | 0.060 |
Why?
|
X-Ray Diffraction | 1 | 2003 | 9 | 0.060 |
Why?
|
Indocyanine Green | 1 | 2023 | 4 | 0.050 |
Why?
|
Gamma Cameras | 1 | 2003 | 1 | 0.050 |
Why?
|
Point Mutation | 1 | 2003 | 6 | 0.050 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2023 | 19 | 0.050 |
Why?
|
Fluorescent Dyes | 1 | 2023 | 32 | 0.050 |
Why?
|
Oxyhemoglobins | 1 | 2002 | 4 | 0.050 |
Why?
|
Sodium Chloride | 1 | 2002 | 6 | 0.050 |
Why?
|
Buffers | 1 | 2002 | 6 | 0.050 |
Why?
|
Hot Temperature | 1 | 2002 | 46 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2003 | 340 | 0.050 |
Why?
|
Antibodies | 1 | 2020 | 28 | 0.040 |
Why?
|
Polymerase Chain Reaction | 1 | 2020 | 37 | 0.040 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2019 | 2 | 0.040 |
Why?
|
Antisickling Agents | 1 | 2019 | 2 | 0.040 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2019 | 5 | 0.040 |
Why?
|
Hypoxia | 1 | 2019 | 12 | 0.040 |
Why?
|
DNA | 1 | 2020 | 64 | 0.040 |
Why?
|
Prognosis | 1 | 2019 | 59 | 0.040 |
Why?
|
Amodiaquine | 1 | 2017 | 2 | 0.040 |
Why?
|
Optical Imaging | 1 | 2015 | 17 | 0.030 |
Why?
|
Anisotropy | 1 | 2012 | 17 | 0.030 |
Why?
|